Observational Prospective Study on Patients Treated With Norditropin®
Tracking Information
Start Date ICMJE | April 2006 |
---|---|
Estimated Primary Completion Date | March 2011 (final data collection date for primary outcome measure) |
Current Primary Outcome Measures ICMJE (submitted: August 14, 2009) |
|
Original Primary Outcome Measures ICMJE | Same as current |
Change History | Complete list of historical versions of study NCT00960128 on ClinicalTrials.gov Archive Site |
Current Secondary Outcome Measures ICMJE (submitted: August 14, 2009) |
|
Original Secondary Outcome Measures ICMJE | Same as current |
Descriptive Information
Brief Title ICMJE | Observational Prospective Study on Patients Treated With Norditropin® |
---|---|
Official Title ICMJE | NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin® |
Brief Summary | This study is conducted in Europe. The aim of this observational study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of children and adults who are already being treated with Norditropin® or who are candidates for treatment with Norditropin®. |
Detailed Description | |
Study Phase | |
Study Type ICMJE | Observational |
Study Design ICMJE | Cohort, Prospective |
Condition ICMJE |
|
Intervention ICMJE |
|
Study Arms / Comparison Groups |
|
Recruitment Information
Estimated Enrollment ICMJE | 10000 | ||||
---|---|---|---|---|---|
Estimated Completion Date | March 2011 | ||||
Estimated Primary Completion Date | March 2011 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| ||||
Gender | Both | ||||
Ages | |||||
Accepts Healthy Volunteers | No | ||||
Contacts ICMJE |
| ||||
Location Countries ICMJE | Argentina, Brazil, Czech Republic, Denmark, Finland, Former Serbia and Montenegro, France, Germany, Hungary, Ireland, Italy, Lithuania, Netherlands, Norway, Russian Federation, Saudi Arabia, Slovenia, Sweden, Switzerland, United Kingdom |
Administrative Information
NCT ID ICMJE | NCT00960128 | ||||
---|---|---|---|---|---|
Responsible Party | Public Access to Clinical Trials, Novo Nordisk A/S | ||||
Study ID Numbers ICMJE | GHLIQUID-3676 | ||||
Study Sponsor ICMJE | Novo Nordisk | ||||
Collaborators ICMJE | |||||
Investigators ICMJE |
| ||||
Information Provided By | Novo Nordisk |
Source: http://clinicaltrials.gov/